Literature DB >> 1463466

Caeruloplasmin biosynthesis by the human uterus.

M L Schilsky1, R J Stockert, J W Pollard.   

Abstract

The blue copper protein caeruloplasmin is synthesized mainly by hepatocytes. An alternative transcript for caeruloplasmin produced in certain extrahepatic tissues, CP-1, contains an additional 12 nucleotides encoding 4 amino acids not present in the hepatic transcript, CP-2 [Yang, Friedrichs, Cupples, Bonifacio, S Sanford, Horton & Bowman (1990) J. Biol. Chem. 265, 10780-10785]. We have demonstrated transcription of caeruloplasmin mRNA by a well-differentiated human uterine epithelial adenocarcinoma cell line, Ishikawa, and by human uterine endometrium and purified endometrial glands. Identical CP-2 nucleotide sequences were obtained for partial caeruloplasmin transcripts from human liver and Ishikawa cells, indicating that CP-2 transcripts are produced by uterine epithelial lining cells. The synthesis of caeruloplasmin protein was demonstrated for Ishikawa cells and another uterine adenocarcinoma cell line, ECC1. Peptide-mapping analysis indicated that caeruloplasmin secreted by Ishikawa cells was structurally identical with the protein synthesized by the human hepatoblastoma cell line HepG2. The secretion of a 135,000-M(r) caeruloplasmin by Ishikawa and ECC1 cells, comparable with that of the human hepatoblastoma cell line, HepG2, indicated similar processing of uterine and hepatic caeruloplasmin. Incorporation of 67Cu into caeruloplasmin was demonstrated for Ishikawa and ECC1 cells, suggesting that the human uterus produces a bioactive form of caeruloplasmin and possesses the necessary metal transporters and intracellular machinery for copper incorporation into this protein.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1463466      PMCID: PMC1132061          DOI: 10.1042/bj2880657

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

1.  Preparation of an apoprotein from ceruloplasmin by reversible dissociation of copper.

Authors:  A G MORELL; I H SCHEINBERG
Journal:  Science       Date:  1958-03-14       Impact factor: 47.728

2.  Transcriptional regulation of ceruloplasmin gene expression during inflammation.

Authors:  J D Gitlin
Journal:  J Biol Chem       Date:  1988-05-05       Impact factor: 5.157

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Peptide mapping in one dimension by limited proteolysis of sodium dodecyl sulfate-solubilized proteins.

Authors:  D W Cleveland
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

6.  Sertoli cells secrete both testis-specific and serum proteins.

Authors:  W W Wright; N A Musto; J P Mather; C W Bardin
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

7.  Localizing of C-reactive protein in synovium of patients with rheumatoid arthritis.

Authors:  J D Gitlin; J I Gitlin; D Gitlin
Journal:  Arthritis Rheum       Date:  1977 Nov-Dec

8.  Human endometrial epithelial cell lines for studying steroid and cytokine actions.

Authors:  S Tabibzadeh; K L Kaffka; P L Kilian; P G Satyaswaroop
Journal:  In Vitro Cell Dev Biol       Date:  1990-12

9.  Sertoli cells synthesize and secrete a ceruloplasmin-like protein.

Authors:  M K Skinner; M D Griswold
Journal:  Biol Reprod       Date:  1983-06       Impact factor: 4.285

10.  Tissue-specific ceruloplasmin gene expression in the mammary gland.

Authors:  J L Jaeger; N Shimizu; J D Gitlin
Journal:  Biochem J       Date:  1991-12-15       Impact factor: 3.857

View more
  1 in total

1.  Intact human ceruloplasmin oxidatively modifies low density lipoprotein.

Authors:  E Ehrenwald; G M Chisolm; P L Fox
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.